{"transactions":[{"id":949873,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:10:22.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":539265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4646012,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":539265},"source":{"system":"sec-edgar","filing":"0001834424-26-000002","document":"wk-form4_1767633019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183442426000002/wk-form4_1767633019.xml","form_type":"4"}},{"id":1313309,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:44:41.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":832033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4106747,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":832033},"source":{"system":"sec-edgar","filing":"0001628280-25-000237","document":"wk-form4_1735937075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000237/wk-form4_1735937075.xml","form_type":"4"}},{"id":1678894,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:21:34.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":616333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3274714,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":616333},"source":{"system":"sec-edgar","filing":"0001703057-24-000006","document":"wk-form4_1705447284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000006/wk-form4_1705447284.xml","form_type":"4"}},{"id":2095495,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:22:32.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":346901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first\ntranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":2658381,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":346901},"source":{"system":"sec-edgar","filing":"0001209191-22-059570","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059570/doc4.xml","form_type":"4"}},{"id":2478519,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-12-09T22:55:42.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":270680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":2311480,"derivative":{"exercise_price":14.55,"expiration_date":"2031-12-07","underlying":"Common Shares","underlying_shares":270680},"source":{"system":"sec-edgar","filing":"0001209191-21-068847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121068847/doc4.xml","form_type":"4"}},{"id":2673265,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Shares","published_at":"2021-06-10T21:01:04.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":1000000,"price":25.5,"value":25500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of the shares  reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), to the extent of 500 Shares, with the purchase by the Reporting Person of 250 Shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 250 Shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."}],"balance_after":250,"source":{"system":"sec-edgar","filing":"0000899243-21-022989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022989/doc4.xml","form_type":"4"}},{"id":2674980,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-06-10T00:30:37.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Previously reported on Form 3 filed on December 11, 2020 and Form 4 filed on December 17, 2020.  The vesting schedule was amended such that all of the shares subject to such option were vested as of March 24, 2021."}],"balance_after":600000,"derivative":{"exercise_price":2.3,"expiration_date":"2030-10-29","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-21-022899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022899/doc4.xml","form_type":"4"}},{"id":2674979,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-06-10T00:30:37.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Previously reported on Form 3 filed on December 11, 2020.  The vesting schedule was amended as follow: 25% of the shares subject to such option vest and become exercisable on August 22, 2020; 6.25% of the shares subject to such option vest and become exercisable on November 22, 2020 and February 22, 2021; 4.70% of the shares subject to such option vest and become exercisable on on July 1, 2022; 8.9% of the shares subject to such option vest and become exercisable on October 1, 2022; 7.4% of the shares subject to such option vest and become exercisable on January 1, 2023; 10.40% of the shares subject to such option vest and become exercisable on April 1, 2023; 8.90% of the shares subject to such option vest and become exercisable on July 1, 2023 and October 1, 2023; 2.70% of the shares subject to such option vest and become exercisable on January 1, 2024;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) and 2.65% of the shares subject to such option vest and become exercisable on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025."}],"balance_after":1250000,"derivative":{"exercise_price":0.32,"expiration_date":"2029-08-22","underlying":"Common Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000899243-21-022899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022899/doc4.xml","form_type":"4"}},{"id":2674978,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Shares","published_at":"2021-06-10T00:30:37.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":250000,"price":2.3,"value":575000.0,"ownership":{"direct":true},"balance_after":1000250,"source":{"system":"sec-edgar","filing":"0000899243-21-022899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022899/doc4.xml","form_type":"4"}},{"id":2674977,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Shares","published_at":"2021-06-10T00:30:37.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":750000,"price":0.32,"value":240000.0,"ownership":{"direct":true},"balance_after":750250,"source":{"system":"sec-edgar","filing":"0000899243-21-022899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022899/doc4.xml","form_type":"4"}},{"id":2939092,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T01:30:08.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":190800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option vest and become exercisable on December 31, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":190800,"derivative":{"exercise_price":20,"expiration_date":"2030-12-10","underlying":"Common Shares","underlying_shares":190800},"source":{"system":"sec-edgar","filing":"0000899243-20-034339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034339/doc4.xml","form_type":"4"}},{"id":2939091,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T01:30:08.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price reported above was converted from the Canadian exercise price of CAD $3.08 using an exchange rate of CAD $1.27840 = US $1.00."},{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable on October 29, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."}],"balance_after":850000,"derivative":{"exercise_price":2.41,"expiration_date":"2030-10-29","underlying":"Common Shares","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0000899243-20-034339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034339/doc4.xml","form_type":"4"}},{"id":2939090,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Shares","published_at":"2020-12-18T01:30:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":250,"price":20,"value":5000.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":250,"source":{"system":"sec-edgar","filing":"0000899243-20-034339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034339/doc4.xml","form_type":"4"}},{"id":2939089,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Shares","published_at":"2020-12-18T01:30:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":250,"price":20,"value":5000.0,"ownership":{"direct":true},"balance_after":250,"source":{"system":"sec-edgar","filing":"0000899243-20-034339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034339/doc4.xml","form_type":"4"}}]}